Analysis of predictive factors for late recurrence of atrial fibrillation after surgical ablation in patients undergoing rheumatic valve surgery

被引:0
作者
Wu, Qingsong [1 ,2 ]
Li, Huangwei [2 ]
Xie, Linfeng [2 ]
Lin, Xinfan [2 ]
Qiu, Zhihuang [1 ]
Chen, Liangwan [1 ]
机构
[1] Fujian Med Univ, Union Hosp, Dept Cardiovasc Surg, Xinquan Rd 29, Fuzhou 350001, Fujian, Peoples R China
[2] Fujian Med Univ, Fuzhou, Fujian, Peoples R China
来源
BMC PULMONARY MEDICINE | 2024年 / 24卷 / 01期
关键词
Rheumatic valve surgery; Atrial fibrillation; Surgical ablation; Late recurrence; MAZE-III PROCEDURE; HEART-DISEASE; IV PROCEDURE; SURVIVAL; SUCCESS; BURDEN; SIZE;
D O I
10.1186/s12890-024-03231-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objectives To identify independent predictors of late recurrence of atrial fibrillation (AF) after surgical ablation in patients undergoing rheumatic valve surgery. Methods A total of 258 patients who underwent surgical ablation for AF with rheumatic heart disease at our hospital between January 2019 and June 2022 were retrospectively included. The patients were followed up for 12 months. Late recurrence was defined as any AF recurrence longer than 30 s between 3 and 12 months. Patients with or without late recurrence were divided into non-recurrence and recurrence groups. Univariate and multivariate analyses were performed to identify the predictors of late recurrence. Results The in-hospital mortality rate was 0.8% (2/258), and the late recurrence rate of AF was 38.4%, including 152 and 95 cases in the non-recurrent and recurrent groups respectively, with a follow-up completion rate of 96.5% (247/256). There were no deaths during follow-up, two patients (0.8%) experienced a stroke, and one patient (0.4%) experienced gastrointestinal hemorrhage. The results of the univariate and multivariate analyses of the preoperative risk factors for late recurrence showed a left atrial (LA) anteroposterior diameter >= 52.9 mm (odds ratio [OR] = 2.366, 95% confidence interval [CI] = 1.089-5.138, P = 0.030], ratio of the superoinferior to the anteroposterior diameters of LA (S-AR) < 1.19 (OR = 4.639, 95% CI = 2.181-9.865, P < 0.001), and AF duration >= 39 months (OR = 6.152, 95% CI = 2.897-13.061, P < 0.001), and cardiothoracic ratio >= 0.63 (OR = 2.716, 95% CI = 1.314-5.612, P = 0.007) were the most significant independent risk factors. Conclusions LA anteroposterior diameter >= 52.9 mm, S-AR < 1.19, and AF duration >= 36 months and cardiothoracic ratio >= 0.63 are independent predictors for late recurrence of AF after surgical ablation in patients undergoing rheumatic valve surgery.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Premature atrial contraction immediately after catheter ablation was associated with late recurrence of atrial fibrillation
    Fujisawa, Tomoki
    Kawakami, Hiroshi
    Nagai, Takayuki
    Miyazaki, Shigehiro
    Akazawa, Yusuke
    Miyoshi, Toru
    Higaki, Akinori
    Seike, Fumiyasu
    Higashi, Haruhiko
    Nishimura, Kazuhisa
    Inoue, Katsuji
    Ikeda, Shuntaro
    Yamaguchi, Osamu
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2023, 46 (02): : 152 - 160
  • [2] Clinical benefits of concomitant surgical ablation for atrial fibrillation in patients undergoing mitral valve surgery
    Kim, Hee Jung
    Han, Kyung-Do
    Kim, Wan Kee
    Cho, Yang Hyun
    Lee, Seung-Hyun
    Je, Hyung Gon
    HEART RHYTHM, 2023, 20 (01) : 3 - 11
  • [3] Concomitant atrial fibrillation ablation in patients undergoing coronary artery bypass and cardiac valve surgery
    Churyla, Andrei
    Desai, Anand
    Kruse, Jane
    Cox, James
    McCarthy, Patrick
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (08) : 2172 - 2178
  • [4] Results of Surgical Ablation for Atrial Fibrillation in Patients with Rheumatic Heart Disease
    Albacker, Turki B.
    Alaamro, Sultan
    Alhothali, Abdulaziz M.
    Arafat, Amr A.
    Algarni, Khaled D.
    Eldemerdash, Ahmed
    Bakir, Bakir M.
    JOURNAL OF THE SAUDI HEART ASSOCIATION, 2022, 34 (04) : 241 - 248
  • [5] Does Surgical Ablation of Atrial Fibrillation Benefit Patients Undergoing Bioprosthetic Valve Replacement?
    Pyo, Won Kyung
    Kim, Ho Jin
    Kim, Joon Bum
    Jung, Sung-Ho
    Choo, Suk Jung
    Chung, Cheol Hyun
    Lee, Jae Won
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2022, 34 (03) : 906 - 915
  • [6] Concomitant ablation of atrial fibrillation in rheumatic mitral valve surgery
    Kim, Wan Kee
    Kim, Ho Jin
    Kim, Joon Bum
    Jung, Sung-Ho
    Choo, Suk Jung
    Chung, Cheol Hyun
    Lee, Jae Won
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (04) : 1519 - +
  • [7] Atrial Fibrillation after Rheumatic Heart Valve Surgery: Incidence, Predictors, and Outcomes
    Ibrahim, Khalid Shaker
    Kheirallah, Khaled
    Mayyas, Fadia
    Waqfi, Nizar
    Al-Zoubi, Nabil
    Van Wagner, David
    THORACIC AND CARDIOVASCULAR SURGEON, 2023, 71 (04) : 297 - 306
  • [8] Evaluation of predictive scores for late and very late recurrence after cryoballoon-based ablation of atrial fibrillation
    Sano, Makoto
    Heeger, Christian-Hendrik
    Sciacca, Vanessa
    Grosse, Niels
    Keelani, Ahmad
    Fahimi, Behzad Hassan Hosseiny
    Phan, Huong Lan
    Reincke, Samuel
    Brueggemann, Ben
    Fink, Thomas
    Liosis, Spyridon
    Vogler, Julia
    Eitel, Charlotte
    Tilz, Roland Richard
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2021, 61 (02) : 321 - 332
  • [9] Evaluation of predictive scores for late and very late recurrence after cryoballoon-based ablation of atrial fibrillation
    Makoto Sano
    Christian-Hendrik Heeger
    Vanessa Sciacca
    Niels Große
    Ahmad Keelani
    Behzad Hassan Hosseiny Fahimi
    Huong Lan Phan
    Samuel Reincke
    Ben Brüggemann
    Thomas Fink
    Spyridon Liosis
    Julia Vogler
    Charlotte Eitel
    Roland Richard Tilz
    Journal of Interventional Cardiac Electrophysiology, 2021, 61 : 321 - 332
  • [10] Risk Factors for Prognosis after the Maze IV Procedure in Patients with Atrial Fibrillation Undergoing Valve Surgery
    Yang, Hui
    Zou, Pu
    He, Yuhu
    Huang, Lingzhi
    Zhou, Xinmin
    Liu, Liming
    Liu, Zhenjiang
    Zhou, Shenghua
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2022, 6 (03) : 135 - 145